NDC 71335-1026

Gabapentin

Gabapentin

Gabapentin is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Gabapentin.

Product ID71335-1026_c3526493-cc6e-492a-bcf2-893eed9d206e
NDC71335-1026
Product TypeHuman Prescription Drug
Proprietary NameGabapentin
Generic NameGabapentin
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2014-01-11
Marketing CategoryANDA / ANDA
Application NumberANDA203244
Labeler NameBryant Ranch Prepack
Substance NameGABAPENTIN
Active Ingredient Strength600 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 71335-1026-1

90 TABLET, FILM COATED in 1 BOTTLE (71335-1026-1)
Marketing Start Date2018-12-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-1026-4 [71335102604]

Gabapentin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203244
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-12-19

NDC 71335-1026-1 [71335102601]

Gabapentin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203244
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-12-19

NDC 71335-1026-3 [71335102603]

Gabapentin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203244
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-12-19

NDC 71335-1026-6 [71335102606]

Gabapentin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203244
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-12-19

NDC 71335-1026-2 [71335102602]

Gabapentin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203244
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-12-19

NDC 71335-1026-5 [71335102605]

Gabapentin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203244
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-12-19

Drug Details

Active Ingredients

IngredientStrength
GABAPENTIN600 mg/1

Pharmacological Class

  • Anti-epileptic Agent [EPC]
  • Decreased Central Nervous System Disorganized Electrical Activity [PE]

NDC Crossover Matching brand name "Gabapentin" or generic name "Gabapentin"

NDCBrand NameGeneric Name
0093-4443GabapentinGabapentin
0093-4444GabapentinGabapentin
0143-3991GabapentinGabapentin
0143-3993GabapentinGabapentin
0143-3994GabapentinGabapentin
0143-9992GabapentinGabapentin
0143-9993GabapentinGabapentin
0143-9994GabapentinGabapentin
67877-222GabapentinGabapentin
67877-223GabapentinGabapentin
67877-224GabapentinGabapentin
67877-428GabapentinGabapentin
67877-429GabapentinGabapentin
68001-006GabapentinGabapentin
68001-007GabapentinGabapentin
68071-1212GABAPENTINGABAPENTIN
68071-1292GabapentinGabapentin
68071-1808GABAPENTINGABAPENTIN
68071-1907GABAPENTINGABAPENTIN
68071-1995GabapentinGabapentin
68071-3230GABAPENTINGABAPENTIN
68071-3046GabapentinGabapentin
68071-3244GabapentinGabapentin
68071-4087GabapentinGabapentin
68071-3086GABAPENTINGABAPENTIN
68071-3383GABAPENTINGABAPENTIN
68071-3314GABAPENTINGABAPENTIN
68071-4049GABAPENTINGABAPENTIN
68071-4241GABAPENTINGABAPENTIN
68071-4099GabapentinGabapentin
68071-4113GabapentinGabapentin
68071-4292GabapentinGabapentin
68071-4180GabapentinGabapentin
68071-4090GabapentinGabapentin
68071-4329GabapentinGabapentin
68071-4603GabapentinGabapentin
68071-4169GabapentinGabapentin
68071-4346GabapentinGabapentin
68071-4366GabapentinGabapentin
68071-4729GabapentinGabapentin
68071-4402GABAPENTINGABAPENTIN
68071-4784GABAPENTINGABAPENTIN
68084-774GabapentinGabapentin
68084-783GabapentinGabapentin
68084-797GabapentinGabapentin
68084-762GabapentinGabapentin
0440-5562GABAPENTINGABAPENTIN
0440-5563GABAPENTINGABAPENTIN
68084-802GabapentinGabapentin
68151-1028GabapentinGabapentin
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.